Ada 2024 Scientific Sessions. Guts) (the “company”), a metabolic therapeutics company focused on pioneering new approaches for the treatment of obesity and type 2 diabetes (t2d), today announced that it will present new preclinical obesity data from its pancreatic gene. Submit your information to see the full list
Registration is underway, and advance registration rates are available through may 9. Final booth payments are due.
84Th Scientific Sessions Of The American Diabetes Association Ada 2024 Annual Meeting.
Plan your time and customize your itinerary, search and browse sessions, abstracts, special events, exhibitors, speakers.
June 19, 2023 | San Diego, Ca.
Guts) (the “company”), a metabolic therapeutics company focused on pioneering new approaches for the treatment of obesity and type 2 diabetes (t2d), today announced that it will present new preclinical obesity data from its pancreatic gene.
Final Booth Payments Are Due.
Images References :
News Updates From The 84Thscientific Sessions.
Guts) (the “company”), a metabolic therapeutics company focused on pioneering new approaches for the treatment of obesity and type 2 diabetes (t2d), today announced that it will present new preclinical obesity data from its pancreatic gene.
Submit Your Information To See The Full List
2024 adept conference achieving diabetes equity in practice today 855:
